Waltham, MA, April 22, 2020 — Trinity Life Sciences, a leader in global
life sciences solutions, announced today the availability of a new brief
regarding the impact of COVID-19 on telehealth.
The brief, based on a survey of 561 healthcare providers
(HCPs) in the U.S., finds that 46 percent of healthcare providers across a wide
range of specialties are using more telemedicine than before COVID-19.
Radiologists, psychiatrists and cardiologists are leading the charge in
providing telemedicine, but many other specialties are also getting on board.
“For most
physicians, practices and life sciences companies, telehealth is still
uncharted territory,” said Neal Dunn, Senior Partner, Head of Insights and Analytics,
Trinity Life Sciences. “Trinity is a resource to help life sciences companies define
the “new normal” for field sales forces, capture insights through market
research and forecast the impact these changes have on brands.”
For access
to the brief, please visit COVID-19 Briefing Series: Telehealth as the New
Normal? How COVID-19 is Shifting the Patient Journey.
About Trinity Life Sciences
Trinity Life Sciences is a trusted strategic partner,
providing evidence-based solutions for the life sciences. With over 20 years of
experience, Trinity is committed to solving clients’ most challenging problems
through exceptional levels of service, powerful tools, and data-driven
insights. Trinity’s range of products and solutions includes industry-leading
benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity
is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.
For
more information:
Elizabeth
Marshall
Trinity
Life Sciences
781-577-6376